Clinical Trials Browser

Phase 2/3 × Lymphoma, Follicular × 1 year × Clear all

NCT06125951 2026-02-18

XanaMIA

Phase 2/3 Active not recruiting

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT04345718 2025-12-09

EXHITENTRE

Phase 2/3 Completed

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders